This article was generated by an automated content engine and was reviewed by a human editor prior to publication. For additional information, read Gain Therapeutics’s 8K filing here.
Gain Therapeutics Company Profile
Gain Therapeutics, Inc, a biotechnology company, develops novel small molecule therapeutics to treat diseases across various therapeutic areas. Its drug discovery platform Magellan discovers novel allosteric binding sites in a disease; identifies proprietary small molecules that bind these sites to modulate protein function; and treats the underlying cause of the disease.
Recommended Stories
- Five stocks we like better than Gain Therapeutics
- Retail Stocks Investing, Explained
- 4 Social Media Stocks Set to Gain as TikTok Ban Looms
- Conference Calls and Individual Investors
- How Do Stock Buybacks Affect Shareholders?
- How to Short a Stock in 5 Easy Steps
- JPMorgan Chase & Co. Stock Can Hit $300 This Year
